1 min read CBD

My Conversation With HempFusion CEO Jason Mitchell - Cannabis Without THC

HempFusion is the only dedicated CBD exposure in the highly regarded $MSOS ETF. The stock is down over 90% in the last year, largely due to political stalemates and slow-moving regulatory changes. With some progress in ’22, it could be due for a rebound.
My Conversation With HempFusion CEO Jason Mitchell - Cannabis Without THC

HempFusion is leading health and wellness CBD company and I had a great time interviewing their CEO Jason Mitchell.  Their proprietary portfolio of products includes a suite of CBD solutions and Probulin probiotics.

Jason and I discussed his background in the space, the scope of the CBD opportunity and he shares who is using hemp-based products. We also cover why 2021 has been a challenging year for cannabis-related stocks and some reasons for optimism in the New Year. Finally, Jason leaves us with two goals for HempFusion in 2022.

HempFusion is the only dedicated CBD exposure in the highly regarded $MSOS ETF. The stock is down over 90% in the last year, largely due to political stalemates and slow-moving regulatory changes. With some progress in ’22, it could be due for a rebound.

Click here for the full interview.


You might also like...

Nov
14
Ascend Q3 2022 Earnings Review with Daniel Neville, Interim Co-CEO and CFO

Ascend Q3 2022 Earnings Review with Daniel Neville, Interim Co-CEO and CFO

Ascend is a leading US multi-state operator that reported better-than-expected revenue and adjusted EBITDA for the third quarter. I interviewed Daniel Neville, Co-CEO and CFO to discuss the robust results.
3 min read
Aug
18
Interview With Abner Kurtin, CEO of Ascend Wellness Holdings

Interview With Abner Kurtin, CEO of Ascend Wellness Holdings

We discuss what drove the strong second quarter, what happened with their deal for MedMen's New York assets and opportunities for federal progress. The conversation concludes with Abner sharing what factors he would consider when building a cannabis-investment portfolio.
1 min read
Apr
28
Interview with Khiron CEO Alvaro Torres: Medical Cannabis In Latin America

Interview with Khiron CEO Alvaro Torres: Medical Cannabis In Latin America

My favorite segment was talking about how they are transitioning from treating chronic pain with cannabis versus opioids. This hits home with me, as my dad is having great results using cannabis for his Chronic Regional Pain Syndrome. Khiron is seeing similar outcomes.
1 min read
Apr
20
Interview with Weedmaps CEO Chris Beals: Amazon Meets Shopify Meets Cannabis

Interview with Weedmaps CEO Chris Beals: Amazon Meets Shopify Meets Cannabis

For investors seeking cannabis exposure in a NASDAQ-listed stock, Weedmaps is an excellent option.
1 min read
Apr
11
Interview with Ascend CEO Abner Kurtin: To The Frustrated Cannabis Investor

Interview with Ascend CEO Abner Kurtin: To The Frustrated Cannabis Investor

In one of my favorite episodes, we discuss how Illinois’ cannabis markets are evolving, New Jersey’s slow transition to adult use, and what is happening with New York and MedMen. We conclude with Abner's message for frustrated cannabis investors.
1 min read